tetano
Editor, Senior Moderator
Public Health Rep. 2012 Nov;127(6):565-71.
Selecting Nonpharmaceutical Strategies to Minimize Influenza Spread: The 2009 Influenza A (H1N1) Pandemic and Beyond.
Barrios LC, Koonin LM, Kohl KS, Cetron M.
Source
Centers for Disease Control and Prevention, Division of Adolescent and School Health, Research Application and Evaluation Branch, Atlanta, GA.
Abstract
Shortly after the influenza A (H1N1) 2009 pandemic began, the U.S. government provided guidance to state and local authorities to assist decision-making for the use of nonpharmaceutical strategies to minimize influenza spread. This guidance included recommendations for flexible decision-making based on outbreak severity, and it allowed for uncertainty and course correction as the pandemic progressed. These recommendations build on a foundation of local, collaborative planning and posit a series of questions regarding epidemiology, the impact on the health-care system, and locally determined feasibility and acceptability of nonpharmaceutical strategies. This article describes -recommendations and key questions for decision makers.
PMID:
23115381
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/23115381
Selecting Nonpharmaceutical Strategies to Minimize Influenza Spread: The 2009 Influenza A (H1N1) Pandemic and Beyond.
Barrios LC, Koonin LM, Kohl KS, Cetron M.
Source
Centers for Disease Control and Prevention, Division of Adolescent and School Health, Research Application and Evaluation Branch, Atlanta, GA.
Abstract
Shortly after the influenza A (H1N1) 2009 pandemic began, the U.S. government provided guidance to state and local authorities to assist decision-making for the use of nonpharmaceutical strategies to minimize influenza spread. This guidance included recommendations for flexible decision-making based on outbreak severity, and it allowed for uncertainty and course correction as the pandemic progressed. These recommendations build on a foundation of local, collaborative planning and posit a series of questions regarding epidemiology, the impact on the health-care system, and locally determined feasibility and acceptability of nonpharmaceutical strategies. This article describes -recommendations and key questions for decision makers.
PMID:
23115381
[PubMed - in process]
http://www.ncbi.nlm.nih.gov/pubmed/23115381